Monochorionic Triplet Gestation after Single Blastocyst Transfer Using Donor Oocytes: Case Report and Review
G Ferri1, M Musto1, G Colombo1
1Unit of Obstetrics and Gynecology, Department of Biomedical and Clinical Sciences, ASST Fatebenefratelli Sacco, Hospital "L. Sacco", University of Milan, Via GB Grassi 74, 20157 Milan, Italy.
Case Reports in Obstetrics and Gynecology
|August 11, 2020
Summary
This case study details a rare monochorionic triamniotic triplet pregnancy resulting from in vitro fertilization (IVF) using donor eggs. Further research is needed to prevent high-risk monozygotic twinning in assisted reproductive technologies.
Area of Science:
- Reproductive Medicine
- Maternal-Fetal Medicine
- Genetics
Background:
- Assisted reproductive technologies (ART) like in vitro fertilization (IVF) are increasingly utilized for infertility treatment.
- The incidence of multiple pregnancies, particularly monozygotic twins, appears higher in IVF compared to natural conception.
- Donor oocyte programs are a subset of IVF offering solutions for specific infertility challenges.
Observation:
- A 43-year-old patient conceived via IVF with donor oocytes.
- Ultrasound at 6 weeks and 5 days gestation revealed a monochorionic triamniotic (MCTA) triplet pregnancy.
- The pregnancy resulted from the transfer of a single blastocyst embryo.
Findings:
- The case presents a rare instance of MCTA triplets following a single embryo transfer in an IVF cycle using donor oocytes.
- This outcome highlights the potential for monozygotic twinning even with single embryo transfer in specific ART contexts.
- The underlying mechanisms contributing to increased monozygotic twinning rates in IVF remain unclear.
Implications:
- This case underscores the importance of careful patient selection and monitoring in ART to mitigate risks associated with multiple gestations.
- Further investigation into the causes of increased monozygotic twinning in IVF is crucial for developing preventative strategies.
- Preventing high-risk multiple pregnancies is essential for reducing obstetric and perinatal morbidity and mortality.


